608125-82-2Relevant academic research and scientific papers
Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists
Baxter, Andrew,Bennion, Colin,Bent, Janice,Boden, Kerry,Brough, Steve,Cooper, Anne,Kinchin, Elizabeth,Kindon, Nicholas,McInally, Tom,Mortimore, Mike,Roberts, Bryan,Unitt, John
, p. 2625 - 2628 (2007/10/03)
A Hit-to-Lead optimisation programme was carried out on the high throughput screening hit, the triazolethiol 1, resulting in the discovery of the potent, orally bioavailable triazolethiol CXCR2 receptor antagonist 45.
